Cartesian Therapeutics, Inc.
RNAC · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $2.80M | $38.9M | −92.8% |
| Operating income | −$143M | −$43.9M | −227% |
| Net income | −$130M | −$77.4M | −68.3% |
Questions
- What was Cartesian Therapeutics's revenue in FY2025?
- $2.80M in FY2025 (Fiscal year ended Dec 31, 2025), −92.8% vs $38.9M a year earlier, per its 10-K filed Mar 2026.
- Was Cartesian Therapeutics profitable in FY2025?
- No: net income was −$130M and operating income −$143M in FY2025.